ESTRADERM
LOE ApproachingNDATRANSDERMALSYSTEM
Approved
Sep 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ESTRADERM is a transdermal estradiol delivery system approved in 1986 for hormone replacement therapy. The product delivers estradiol through the skin as a small molecule, providing systemic hormone replacement for menopausal symptoms and related indications. It represents a landmark formulation innovation in HRT, shifting delivery from oral to transdermal administration.
LOE Approaching
As LOE approaches, expect consolidation of brand resources and shift toward specialty positioning or generic defense strategies; team size likely contracting.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ESTRADERM in its LOE phase offers experience in defensive brand management, generic competition strategy, and market transition planning—valuable skills for managing mature portfolios. However, limited growth trajectory and zero linked job openings signal this is a consolidation role rather than a career accelerator.
Brand ManagerMarket Access Manager
Worked on ESTRADERM at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.